Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

Michela Tassara, Konstanze Döhner, Peter Brossart, Gerhard Held, Katharina Götze, Heinz-A Horst, Mark Ringhoffer, Claus-Henning Köhne, Stephan Kremers, Aruna Raghavachar, Gerald Wulf, Heinz Kirchen, David Nachbaur, Hans Günter Derigs, Mohammed Wattad, Elisabeth Koller, Wolfram Brugger, Axel Matzdorff, Richard Greil (Co-author), Gerhard HeilPeter Paschka, Verena I Gaidzik, Martin Göttlicher, Hartmut Döhner, Richard F Schlenk

Research output: Contribution to journalOriginal Article (Journal)peer-review

68 Citations (Web of Science)
Original languageEnglish
Pages (from-to)4027-4036
JournalBLOOD
Volume123
Issue number26
DOIs
Publication statusPublished - 2014

Keywords

  • HISTONE DEACETYLASE
  • ELDERLY-PATIENTS
  • HDAC INHIBITORS
  • EARLY DEATH
  • AML HD98-B
  • PHASE-III
  • TRIAL
  • AGE
  • MUTATIONS
  • OUTCOMES

Cite this